Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy m locally advanced non-small cell lung cancer: Analysis of early and late pulmonary morbidity

Seminars in Radiation Oncology

Volumn 9, Issue 2 SUPPL. 1, 1999, Pages 136-147

  Robert, F ^a   Childs, H A ^a   Spencer, S A ^a   Redden, D T ^a   Hawkins, M M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CISPLATIN; CORTICOSTEROID; ETOPOSIDE; PACLITAXEL; VINBLASTINE;

ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FORCED EXPIRATORY VOLUME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; LYMPHOCYTOPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; THORAX RADIOGRAPHY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOPENIA; MALE; PACLITAXEL; RESPIRATORY FUNCTION TESTS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 0032954895     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)